title: HER-2 overexpression and targeted treatment by trastuzumab in a very old patient with gastric cancer.
authors.affiliation: Inui Clinic, Kagoshima, Japan.
authors.forename: T
authors.initials: T
authors.lastname: Inui
authors.forename: A
authors.initials: A
authors.lastname: Asakawa
authors.forename: Y
authors.initials: Y
authors.lastname: Morita
authors.forename: S
authors.initials: S
authors.lastname: Mizuno
authors.forename: T
authors.initials: T
authors.lastname: Natori
authors.forename: A
authors.initials: A
authors.lastname: Kawaguchi
authors.forename: M
authors.initials: M
authors.lastname: Murakami
authors.forename: Y
authors.initials: Y
authors.lastname: Hishikawa
authors.forename: A
authors.initials: A
authors.lastname: Inui
mesh_terms: D000230:Adenocarcinoma / Q000188:drug therapy* / Q000378:metabolism / Q000556:secondary; D000369:Aged, 80 and over; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D017809:Fatal Outcome; D005784:Gene Amplification / Q000235:genetics; D018734:Genes, erbB-2; D006801:Humans; D007564:Japan; D008113:Liver Neoplasms / Q000188:drug therapy* / Q000378:metabolism / Q000556:secondary; D008297:Male; D009363:Neoplasm Proteins / Q000378:metabolism; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000378:metabolism; D013274:Stomach Neoplasms / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology; D000068878:Trastuzumab
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents; D009363:Neoplasm Proteins; D018719:Erb-b2 Receptor Tyrosine Kinases; D000068878:Trastuzumab